Experimental drug for tough leukemias hits dead end
Disease control
Terminated
This early-phase trial tested an oral drug called NMS-03592088 in 63 adults with acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) that had come back or not responded to standard treatments. The goal was to check safety, find the right dose, and see if it cou…
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC